Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation volume 35, pages 577–582 (2005)Cite this article

Summary:

Bloodstream infection (BSI) is a significant complication following allogeneic hematopoietic stem cell transplantation (allo-SCT). Corticosteroids mask inflammatory responses, delaying the initiation of antibiotics. We reviewed medical records of 69 allo-SCT patients who had been on >0.5 mg/kg prednisolone to investigate the efficacy of weekly surveillance blood cultures. A total of 36 patients (52%) had positive cultures, 25 definitive BSI and 11 probable BSI. Pathogens in definitive BSI were Staphylococcus epidermidis (n=7), S. aureus (n=4), Entrococcus faecalis (n=3), Pseudomonas aeruginosa (n=5), Acenitobacter lwoffii (n=4), and others (n=10). The median interval from the initiation of corticosteroids to the first positive cultures was 24 days (range, 1–70). At the first positive cultures, 15 patients with definitive BSI were afebrile. Four of them remained afebrile throughout the period of positive surveillance cultures. Patients with afebrile BSI tended to be older (P=0.063), and had in-dwelling central venous catheters less frequently than febrile patients (P<0.0001). Bloodstream pathogens were directly responsible for death in two patients with afebrile BSI. This study demonstrates that cortisosteroid frequently masks inflammatory reactions in allo-SCT recipients given conrticosteroids, and that surveillance blood culture is only diagnostic clue for ‘occult’ BSI.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Collin BA, Leather HL, Wingard JR et al. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001; 33: 947–953.

    Article  CAS  Google Scholar 

  2. Kruger W, Russmann B, Kroger N et al. Early infections in patients undergoing bone marrow or blood stem cell transplantation – a 7 year single centre investigation of 409 cases. Bone Marrow Transplant 1999; 23: 589–597.

    Article  CAS  Google Scholar 

  3. Mohty M, Faucher C, Vey N et al. High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation. Bone Marrow Transplant 2000; 26: 251–255.

    Article  CAS  Google Scholar 

  4. Ninin E, Milpied N, Moreau P et al. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 2001; 33: 41–47.

    Article  CAS  Google Scholar 

  5. Junghanss C, Boeckh M, Carter RA et al. Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. Blood 2002; 99: 1978–1985.

    Article  CAS  Google Scholar 

  6. Arns da Cunha C, Weisdorf D, Shu XO et al. Early gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis. Bone Marrow Transplant 1998; 21: 173–180.

    Article  CAS  Google Scholar 

  7. Kolbe K, Domkin D, Derigs HG et al. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 143–147.

    Article  CAS  Google Scholar 

  8. Sparrelid E, Hagglund H, Remberger M et al. Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection. Bone Marrow Transplant 1998; 22: 795–800.

    Article  CAS  Google Scholar 

  9. Anonymous. Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Ann Intern Med 1993; 119 (Part 1): 584–593.

  10. Anonymous. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. The EORTC International Antimicrobial Therapy Cooperative Group. N Engl J Med 1987; 317: 1692–1698.

  11. Sayer HG, Longton G, Bowden R et al. Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention. Blood 1994; 84: 1328–1332.

    CAS  Google Scholar 

  12. Wisplinghoff H, Seifert H, Wenzel RP et al. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003; 36: 1103–1110.

    Article  Google Scholar 

  13. Woo PC, Wong SS, Lum PN et al. Cell-wall-deficient bacteria and culture-negative febrile episodes in bone-marrow-transplant recipients. Lancet 2001; 357: 675–679.

    Article  CAS  Google Scholar 

  14. Kami M, Hamaki T, Kusumi E et al. Cell-wall-deficient bacteria. Lancet 2001; 357: 1885–1886.

    Article  CAS  Google Scholar 

  15. Serody JS, Berrey MM, Albritton K et al. Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplant 2000; 26: 533–538.

    Article  CAS  Google Scholar 

  16. Levin PD, Hersch M, Rudensky B et al. Routine surveillance blood cultures: their place in the management of critically ill patients. J Infect 1997; 35: 125–128.

    Article  CAS  Google Scholar 

  17. Anonymous. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2000; 6: 659–713.

  18. Garner J, Jarvis W, Emori T et al. CDC definitions for nosocomial infections. In: Olmsted R (ed.). APIC Infection Control and Applied Epidemiology. Mosby: St Louis, 1996, pp A1–A20.

    Google Scholar 

  19. Weinstein MP, Towns ML, Quartey SM et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24: 584–602.

    Article  CAS  Google Scholar 

  20. Kanda Y, Mineishi S, Saito T et al. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 689–692.

    Article  CAS  Google Scholar 

  21. Hughes WT, Armstrong D, Bodey GP et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730–751.

    Article  Google Scholar 

  22. Engelhard D, Elishoov H, Strauss N et al. Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. A 5-year prospective study. Transplantation 1996; 61: 430–434.

    Article  CAS  Google Scholar 

  23. Engels EA, Ellis CA, Supran SE et al. Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk. Clin Infect Dis 1999; 28: 256–266.

    Article  CAS  Google Scholar 

  24. Aronson MD, Bor DH . Blood cultures. Ann Intern Med 1987; 106: 246–253.

    Article  CAS  Google Scholar 

  25. Grace CJ, Lieberman J, Pierce K et al. Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy. Clin Infect Dis 2001; 32: 1651–1655.

    Article  CAS  Google Scholar 

  26. Lina B, Forey F, Tigaud JD et al. Chronic bacteraemia due to Staphylococcus epidermidis after bone marrow transplantation. J Med Microbiol 1995; 42: 156–160.

    Article  CAS  Google Scholar 

  27. Engels EA, Lau J, Barza M . Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. J Clin Oncol 1998; 16: 1179–1187.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematopoietic Stem Cell Transplantation Unit, The National Cancer Center Hospital, Japan

    A Chizuka, M Kami, N Murashige, Y Kishi, T Hamaki, S-W Kim, A Hori, R Kojima, S-i Mori & R Tanosaki

  2. Department of Cell Therapy & Transplantation Medicine, University of Tokyo, Japan

    Y Kanda

  3. Japan Medical Association Research Institute, Japan

    H Gomi & Y Takaue

Authors
  1. A Chizuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Kami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y Kanda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N Murashige
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y Kishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T Hamaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S-W Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Hori
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. R Kojima
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. S-i Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. R Tanosaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. H Gomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Y Takaue
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

for the Tokyo Stem Cell Transplantation Consortium

Corresponding author

Correspondence to M Kami.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chizuka, A., Kami, M., Kanda, Y. et al. Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 35, 577–582 (2005). https://doi.org/10.1038/sj.bmt.1704830

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704830

Keywords

This article is cited by

Search

Advanced search

Quick links